by Ket Patel | Mar 24, 2012 | All Articles For Neurology, Neuro-Oncology
Electrocutaneous direct nerve stimulation via a device that scrambles “pain” and “no pain” signals reduced pain scores in preliminary studies involving patients with refractory chemotherapy-induced peripheral neuropathy, post-herpetic...
by Ket Patel | Mar 18, 2012 | All Articles For Neurology, Stroke
Levels of air pollution that fall within the amounts deemed safe in current U.S. standards for air quality were associated with a significant increase the risk for acute ischemic stroke after short-term exposure and accelerated cognitive decline after long-term...
by Ket Patel | Mar 17, 2012 | All Articles For Neurology, Stroke
Two new risk assessment scores predicted the likelihood of a symptomatic intracranial hemorrhage after ischemic stroke treatment with more than 70% accuracy. Predictive rules such as these are important because there is still no large-scale prospective study that...
by Ket Patel | Mar 16, 2012 | All Articles For Neurology, Stroke
A granulocyte colony-stimulating drug did not protect brain tissue or improve functional outcomes after ischemic stroke. Researchers had high hopes for filgrastim, which is approved in Europe for chemotherapy-induced neutropenia. In vivo and in vitro studies indicated...
by Ket Patel | Mar 15, 2012 | All Articles For Neurology, Stroke
The potential advantages of tenecteplase, a modified form of tissue plasminogen activator engineered to outperform the native molecule, finally shone through for treating patients with acute ischemic stroke. A head-to-head comparison of tenecteplase against...
